goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page

Diabetes in Pregnancy - Part 2 Management, Delivery and Postpartum

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

Diabetes In Pregnancy Series

Sponsored by The Indian Health Service Clinical Support Center

PART 2: Management, delivery, and postpartum

16. Reference Texts and Articles

If you have been unable to obtain the previous references online, then try these paper-based materials.

Reference Texts

1. Obstetrics: Normal and Problem Pregnancies, 4th Edition. Gabbe SG, Neibyl JR, Simpson JL (Eds.). Diabetes mellitus, Chapter 32. Churchill Livingstone, New York, 2002. Pages 1081-1116 (level III).

2. Williams Obstetrics. Diabetes, 21st Edition. Cunningham GF, et al (Eds.) Section 12, No. 51, pp. 1359-1382. McGraw-Hill, 2001 (Level III).

3 . Davidson, MB. Diabetes Mellitus: Diagnosis and Treatment. Volume 1. John Wiley and Sons, New York. 1981 (Level III).

4 . ACOG Practice Bulletin. Gestational diabetes. Number 30, September 2001. Obstet Gynecol. 2001 Sep;98(3):525-38 (Level III).

5. ACOG Practice Bulletin No. 40, November 2002 – Shoulder Dystocia
Obstet Gynecol 2002 Nov;100(5 Pt 1):1045-50 (Level III)

6. ACOG Practice Bulletin No. 17, June 2000 – Operative vaginal delivery Obstet Gynecol 2000 June 95, (6) American College of Obstetricians and Gynecologists. Washington, D.C. (Level III)

7. ACOG Practice Bulletin No. 22, November 2000 – Fetal macrosomia Obstet Gynecol 2000 Nov 96, (5) American College of Obstetricians and Gynecologists. Washington, D.C. (Level III)

8. ACOG Practice Bulletin No. 10, November 1999 – Induction of labor. Obstet Gynecol 1999 Nov 94, (5) American College of Obstetricians and Gynecologists. Washington, D.C. (Level III)

Article References

-American Diabetes Association ExitDisclaimer : The prevention or delay of type 2 diabetes. Diabetes Care 2004;27(suppl 1):S47. (Level III)

- American College of Obstetricians and Gynecologists. Consultation – Diagnosis of Gestational Diabetes. April 12, 1993 Washington, D.C.
For copies, contact Elaine Locke or Neil Murphy

-Andersen O, Hertel J, Schmolker L, Kuhl C. Influence of the maternal plasma glucose concentration at delivery on the risk of hypoglycaemia in infants of insulin-dependent diabetic mothers. Acta Paediatr Scand 1985 Mar;74(2):268-73 (Level III)

- Buchanan TA, et al Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 2002 Sep;51(9):2796-803 (Level I)

-Bung P, Bung C, Artal R, Khodiguian N, Fallenstein F, Spätling L. Therapeutic exercise for insulin-requiring gestational diabetics: effects on the fetus—results of a randomized prospective longitudinal study. J Perinat Med 1993;21:125–137 (Level II-2)

- Chiasson JL, et al Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA. 2003 Jul 23;290(4):486-94. (Level I)

-Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol 1998 May;178(5):922-5 (Level II-2)

-Curet LB, Izquierdo LA, Gilson GJ, Schneider JM, Perelman R, Converse J. Relative effects of antepartum and intrapartum maternal blood glucose levels on incidence of neonatal hypoglycemia. J Perinatol 1997 Mar-Apr;17(2):113-5 (Level III)

Diabetes Prevention Program Research Group Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. 2003 Sep;26(9):2518-23. (Level I)

-The Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002 Dec;25(12):2165-71 (Level III)

-Dyck RF, Sheppard MS, Cassidy H, Chad K, Tan L, Van Vliet SH. Preventing NIDDM among aboriginal people: is exercise the answer? Description of a pilot project using exercise to prevent gestational diabetes. Int J Circumpolar Health 1998;57 Suppl 1:375-8 (Level III)

-Espey E, Steinhart J, Ogburn T, Qualls C. Depo-provera associated with weight gain in Navajo women. Contraception 2000 Aug;62(2):55-8 (Level II-2)

-Glueck CJ, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002 Mar;77(3):520-5 (Level II-2)

-Jovanovic-Peterson L, Durak EP, Peterson CM. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes. Am J Obstet Gynecol 1989;161:415–419 (Level II-1)

-Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002 Oct;25(10):1862-8 (Level III)

-Kjos SL et al. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993 Sep;169(3):611-5.

-Kjos SL, Leung A, Henry OA, Victor MR, Paul RH, Medearis AL. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 1995 Nov;173(5):1532-9 (Level II-3)

-Kjos SL, Peters RK, Xiang A, Thomas D, Schaefer U, Buchanan TA. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. JAMA 1998 Aug 12;280(6):533-8 (Level II-2)

-Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, Bryne JD, Sutherland C, Montoro MN, Buchanan TA. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia.
Diabetes Care 2001 Nov;24(11):1904-10 (Level I)

-Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 Feb 7;346(6):393-403 (Level I)

-Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 2000 Oct 19;343(16):1134-8 (Level I)

-Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol 1996 Jul;13(5):293-6 (Level II-2)

-McFarland MB, Langer O, Conway DL, Berkus MD. Dietary therapy for gestational diabetes: how long is long enough? Obstet Gynecol 1999 Jun;93(6):978-82 (Level II-3)

-Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, Yale JF, Zinman B, Lillie D. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association. CMAJ 1998;159 Suppl 8:S1-29 (Level III)

-Naylor CD, Sermer M, Chen E, Sykora K. Cesarean delivery in relation to birth weight and gestational glucose tolerance: pathophysiology or practice style? Toronto Trihospital Gestational Diabetes Investigators. JAMA 1996 Apr 17;275(15):1165-70 (Level II-2)

- Pan XR, et al Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537-44. (Level I)

-Pettitt DJ, Bennett PH, Saad MF, Charles MA, Nelson RG, Knowler WC. Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes. 1991 Dec;40 Suppl 2:126-30.

-Rao SS, Disraeli P, McGregor T: Impaired glucose tolerance and impaired fasting glucose. Am Fam Physician 2004;69:1961-8,1971-2 (Level III)

-Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 May 3;344(18):1343-50 (Level I)

-U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44(11):1249-58. Erratum in: Diabetes 1996 Nov;45(11):1655. (Level I)

Uusitupa M, et al The Finnish Diabetes Prevention Study. Br J Nutr. 2000 Mar;83 Suppl 1:S137-42. (Level I)

15. A.C.O.G. resources ‹ Previous | Next › 17. Posttest Evaluation

up arrow Return to top of page

This file last modified: Monday November 5, 2007  3:31 PM